Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by newdaydawningon Aug 08, 2019 2:52pm

55 Views

Post# 30008100

RE:questions and answers

In answer to #3. Without the positive NRs, the financing may have come in at 25 cents per unit.

tomchoco wrote: 1) Who was in charge of this prospectus?

2)When was it decided that the price of 30/35 was to be the number?

3)Were Pr's used to prop up the price and lure in unsuspecting buyers right before the low number was announced?

4)Is Roger's wife the curent CFO?

5)Did anyone at the company sell exisitng holdings to participate in the new PP?

6)Can they cancel this debacle and find alternate funding or lower the pricing to facilitate the maximum amount needed?